Transcatheter Aortic Valve Implantation: Where are we in 2020?

AUTOR(ES)

Sarmento-Leite, Rogerio; Oliveira Junior, Gilberto Eder de

FONTE

Int. J. Cardiovasc. Sci.

DATA DE PUBLICAÇÃO

2020-10

RESUMO

Abstract Aortic stenosis is an insidious disease of rapid progression after the onset of symptoms. Aortic valve replacement surgery is a well-established therapy that reduces symptoms and increases survival rates. However, the procedure may be associated with high operative mortality rates and promote comorbidity. Depending on the local reality, the prevalence of patients considered inoperable (due to medical comorbidities and age) may achieve 30%. For these patients, transcatheter aortic valve implantation (TAVI) was initially indicated; over time, the method has advanced technologically and been simplified, and become an alternative therapy for patients at low and intermediate surgical risk also, and considered one of the major advances of modern medicine.

Documentos Relacionados

• Comparison of anesthesia management in transcatheter aortic valve implantation: a retrospective cohort study
• Conscious sedation versus general anesthesia for transcatheter aortic valve implantation: a retrospective study
• Transcatheter implantation of aortic valve bioprosthesis: changing paradigms
• Connective tissue diseases following silicone breast implantation: where do we stand?
• Impact of Prosthesis-Patient Mismatch on 1-Year Outcomes after Transcatheter Aortic Valve Implantation: Meta-analysis of 71,106 Patients